Board meeting on November 3, 2026 to consider unaudited results for quarter and half year ended September 30, 2026
Board meeting scheduled for Tuesday, November 3, 2026.
By ScoutQuest · · 2 min read
- Board meeting date
- Tuesday, November 3, 2026
- Agenda
- approval of unaudited financial results for the quarter and half year ended September 30, 2026
- Trading window
- closed until Thursday, November 5, 2026; opens for trading on and from Friday, November 6, 2026
Zydus Wellness has informed the stock exchanges that a meeting of its Board of Directors will be held on Tuesday, November 3, 2026.
What the board will consider
- Approval of the unaudited financial results for the quarter and half year ended September 30, 2026
- Other agenda items, apart from the results
Trading window dates
- The trading window will remain closed until Thursday, November 5, 2026
- It will open for trading on and from Friday, November 6, 2026
- This applies to all the Directors and Designated Persons of the company
The notice is dated October 15, 2026.
Why this intimation is put out
This is a prior notice telling the market when the board will meet and what it will take up. The results themselves are not part of this update. The numbers that describe the company's performance for the quarter and half year ended September 30, 2026 will come with the results once the board approves them.
What the trading window means
The window is the period during which Directors and Designated Persons of the company are restricted from dealing in its shares, so that they do not trade while in possession of unpublished price-sensitive information. It stays shut until Thursday, November 5, 2026, that is, until after the board meeting and the results, and reopens on Friday, November 6, 2026. The update names the persons this applies to: all the Directors and Designated Persons of the company.
How a retail investor can read this
Board meeting intimations are routine and are made ahead of every results announcement, so the dates are the main information here. The useful detail for a shareholder is the timing: the results for the quarter and half year ended September 30, 2026 are scheduled to be considered on November 3, 2026, and the trading window reopens on November 6, 2026.
Also from Zydus Wellness
Says FSSAI notice on product claims has no material impact; reply already shared
23 Oct 2026
Zydus Wellness schedules Q2FY27 results conference call with analysts on November 3, 2026
19 Oct 2026
ESG rating of 72 for FY2026 assigned; placed in 'leader' category
16 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.